132 related articles for article (PubMed ID: 2672784)
1. Klebsiella pneumoniae bacteremia in children. Fifty-seven cases in 10 years.
Bonadio WA
Am J Dis Child; 1989 Sep; 143(9):1061-3. PubMed ID: 2672784
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcomes for bloodstream infections with extended-spectrum beta -lactamase-producing Klebsiella pneumoniae ; Findings of the nosocomial surveillance system in Hungary.
Szilágyi E; Füzi M; Böröcz K; Kurcz A; Tóth A; Nagy K
Acta Microbiol Immunol Hung; 2009 Sep; 56(3):251-62. PubMed ID: 19789140
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care.
Tseng CP; Wu HS; Wu TH; Lin YT; Fung CP
J Microbiol Immunol Infect; 2013 Jun; 46(3):217-23. PubMed ID: 22832028
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of clinical and microbiological aspects of Klebsiella oxytoca bacteremia over a 10-year period.
Kim BN; Ryu J; Kim YS; Woo JH
Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):419-26. PubMed ID: 12111596
[TBL] [Abstract][Full Text] [Related]
5. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.
Marra AR; Wey SB; Castelo A; Gales AC; Cal RG; Filho JR; Edmond MB; Pereira CA
BMC Infect Dis; 2006 Feb; 6():24. PubMed ID: 16478537
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
[TBL] [Abstract][Full Text] [Related]
8. Changing trends in clinical characteristics and antibiotic susceptibility of
Hyun M; Noh CI; Ryu SY; Kim HA
Korean J Intern Med; 2018 May; 33(3):595-603. PubMed ID: 29117671
[TBL] [Abstract][Full Text] [Related]
9. Infection in burn patients in a referral center in Colombia.
Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
Lee JA; Kang CI; Joo EJ; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Ko KS; Lee NY; Song JH
Microb Drug Resist; 2011 Jun; 17(2):267-73. PubMed ID: 21388296
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Yang CC; Wu CH; Lee CT; Liu HT; Chen JB; Chiu CH; Chen CH; Chuang FR
Int J Infect Dis; 2014 Nov; 28():3-7. PubMed ID: 25200093
[TBL] [Abstract][Full Text] [Related]
12. Polymicrobial bacteremia in children. An 11-year experience.
Bonadio WA
Am J Dis Child; 1988 Nov; 142(11):1158-60. PubMed ID: 3177321
[TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
Han SB; Jung SW; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK; Park YJ
Microb Drug Resist; 2015 Apr; 21(2):244-51. PubMed ID: 25398058
[TBL] [Abstract][Full Text] [Related]
14. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy.
Korvick JA; Bryan CS; Farber B; Beam TR; Schenfeld L; Muder RR; Weinbaum D; Lumish R; Gerding DN; Wagener MM
Antimicrob Agents Chemother; 1992 Dec; 36(12):2639-44. PubMed ID: 1482131
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
Liu SW; Chang HJ; Chia JH; Kuo AJ; Wu TL; Lee MH
J Microbiol Immunol Infect; 2012 Apr; 45(2):113-9. PubMed ID: 22154994
[TBL] [Abstract][Full Text] [Related]
16. Klebsiella bacteremia: an analysis of 100 episodes.
García de la Torre M; Romero-Vivas J; Martínez-Beltrán J; Guerrero A; Meseguer M; Bouza E
Rev Infect Dis; 1985; 7(2):143-50. PubMed ID: 3890094
[TBL] [Abstract][Full Text] [Related]
17. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia.
Díaz A; Ortiz DC; Trujillo M; Garcés C; Jaimes F; Restrepo AV
Pediatr Infect Dis J; 2016 Mar; 35(3):237-41. PubMed ID: 26569194
[TBL] [Abstract][Full Text] [Related]
19. Klebsiella pneumoniae bacteremia in the community hospital.
Haddy RI; Lee M; Sangal SP; Walbroehl GS; Hambrick CS; Sarti GM
J Fam Pract; 1989 Jun; 28(6):686-90. PubMed ID: 2656904
[TBL] [Abstract][Full Text] [Related]
20. Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Aracil-García B; Oteo-Iglesias J; Cuevas-Lobato Ó; Lara-Fuella N; Pérez-Grajera I; Fernández-Romero S; Pérez-Vázquez M; Campos J;
Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):480-486. PubMed ID: 27469416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
